Neuroimaging and CSF Biomarker RFP

    From Institute for the Study of Aging Inc. (Alzheimer's Drug Discovery Foundation)

    The mission details of the funder are not explicitly provided in the given description.

    Type of Support

    Overview

    The grant program aims to advance the development and validation of biomarkers for Alzheimer's disease and related dementias, addressing a clear clinical need. It prioritizes biomarkers that have a defined context of use, demonstrate an advantage over existing ones, and show potential for commercialization or clinical application. The focus is on: developing novel PET ligands for clinical trials, supporting innovative CSF biomarkers, validating MRI approaches in larger cohorts, and creating new measures of functional activity such as EEG. High priority areas include novel biomarkers of neuroinflammation, synaptic integrity, autophagy, and TDP-43, among others. The grant offers up to $600,000 depending on the stage and scope of research, for one year, with the possibility of additional funding, covering only direct costs.

    Eligibility

    Organization's Location
    sit aute
    Program Location
    non
    Organization Type
    Sint aliqua aute
    Ad amet aliquip
    Reprehenderit dolore
    Other
    • culpa aliquip exercitation
    up to 6M

    Submission

    Schedule
    Step 1: nostrud eu officia
    Application deadline
    Mar 18, 2025
    Step 2: exercitation aliqua (esse dolore)
    Review Criteria

    minim adipisicing anim sint reprehenderit fugiat

    5 of 5 free pages viewed this month
    Sign up to view this and 11K+ more grant opportunities
    Already have an account?Log in